Browse the corpus

REFERENCES Abildgaard CF, Simone JV, Corrigan JJ, et al, “Treatment of Hemophilia With Glycine-Precipitated Factor VIII,” N Engl J Med , 1966, 275(9):471-5. [PubMed 5917942 ] Berntorp E, “Impact of Replacement Therapy on the Evolution of HIV Infection in Hemophiliacs,” Thromb Haemost , 1994, 71(6):678-83. [PubMed 7974331 ] Lusher JM, “Transfusion Therapy in Congenital Coagulopathies,” Hematol Oncol Clin North Am , 1994, 8(6):1167-80. [PubMed 7860443 ] Manucci PM, “Impact of Recombinant Factor VIII on Hemophilia Care,” Vox Sang , 1994, 67(Suppl 3):49-52. [PubMed 7975511 ] Nilsson IM, Berntorp E, Lofqvist T, et al, “Twenty-Five Years' Experience of Prophylactic Treatment in Severe Haemophilia A and B,” J Intern Med , 1992, 232(1):25-32. [PubMed 1640190 ] Peterson CW, “Treating Hemophilia,” Am Pharm , 1994, NS34(8):57-67. White GC, Rosendaal F, Aledort LM, et al, “Definitions in Hemophilia. Recommendation of the Scientific Subcommittee on Factor VIII and Factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis,” Thromb Haemost , 2001, 85(3):560. [PubMed 11307831 ] Topic 8825 Version 37.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0604-61.55.141.10-1AFF26D322-S244013.14]